Herbalife Ltd. last reported quarterly results on Nov 2, 2026, for Q3 FY2026 (the quarter ended Sep 30, 2026): revenue of $1.4 billion (+6.0% year over year) and diluted EPS of $0.55. It usually reports 14–49 days after a quarter ends. Based on that pattern, the next release is estimated for around Feb 17, 2027.
Results for Q4 FY2026, the quarter ending around Dec 31, 2026. Expected on a Wednesday. Based on last year's release for the same quarter on Feb 18, 2026. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 14–49 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Nov 2, 2026
33 days after quarter end
|
Q3 FY2026
ended Sep 30, 2026
|
1,350
+6.0%
|
59
+36.1%
|
0.55
+31.0%
|
|
Aug 5, 2026
36 days after quarter end
|
Q2 FY2026
ended Jun 30, 2026
|
1,327
+5.4%
|
-26
-153.3%
|
-0.25
-152.1%
|
|
Apr 14, 2026
14 days after quarter end
|
Q1 FY2026
ended Mar 31, 2026
|
1,317
+7.8%
|
62
+22.8%
|
0.57
+16.3%
|
|
Feb 18, 2026
49 days after quarter end
|
Q4 FY2025
ended Dec 31, 2025
|
1,283
+6.3%
|
85
-52.0%
|
0.82
-53.2%
|
|
Nov 5, 2025
36 days after quarter end
|
Q3 FY2025
ended Sep 30, 2025
|
1,274
+2.7%
|
43
-8.9%
|
0.42
-8.7%
|
|
Aug 6, 2025
37 days after quarter end
|
Q2 FY2025
ended Jun 30, 2025
|
1,259
-1.7%
|
49
+948.9%
|
0.48
+860.0%
|
|
Apr 30, 2025
30 days after quarter end
|
Q1 FY2025
ended Mar 31, 2025
|
1,222
-3.4%
|
50
+107.4%
|
0.49
+104.2%
|
|
Feb 19, 2025
50 days after quarter end
|
Q4 FY2024
ended Dec 31, 2024
|
1,207
-0.6%
|
178
+1644.1%
|
1.74
+1620.2%
|
Company profile
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (SIC 5122)
- Listed as
- HLF (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- George Town, Cayman Islands
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1180262
- Former names
- HERBALIFE NUTRITION LTD. (until Apr 11, 2023); WH HOLDINGS CAYMAN ISLANDS LTD (until Dec 13, 2004)
Other Wholesale-Drugs, Proprietaries & Druggists' Sundries companies
- Mckesson Corp MCK
- Cencora, Inc. COR
- Cardinal Health Inc CAH
- Nu Skin Enterprises, Inc. NUS
- EnerSyn Global Inc. ESYN
- Cosmos Health Inc. COSM
- DataMeds AI, Inc. MEDS
- Cellyan Biotechnology Co., Ltd HKPD
All 11 Wholesale-Drugs, Proprietaries & Druggists' Sundries companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.